
David R. Axline, MD, FACC
@pu84
Princeton University, University of Pittsburgh School of Medicine, Hospital of the University of Pennsylvania, U. Mass. Medical Center, NCH Heart Institute
ID: 29874400
09-04-2009 00:52:48
1,1K Tweet
517 Followers
1,1K Following

Another day at the NCH Rooney Heart Institute 👏great save and team work! NCH Healthcare System #Robert_Pascotto Ricardo Martinez-Ruiz Gaston A. Cudemus, MD Stephen Dorazio Viviana Navas, MD David R. Axline, MD, FACC Brian Solomon


Excited to announce & welcome Dee Dee Wang MD World renowned Multimodality Imager as our new Head of🫀Imaging NCH Rooney Heart Institute advanced expertise SH imaging, TEE, CT, MR, 3D printing, #research & #innovation American College of Cardiology TCTMD Cardiovascular Research Foundation PCRonline 🫀 CSI Congress JACC Journals American Society of Echocardiography




REGISTER NOW (live or virtual) and visit us in Naples, Florida. Feb 21-22 NCH Healthcare System Viviana Navas, MD Thomas Caranasos William W. O'Neill Dee Dee Wang MD Dinesh Sharma MD MPH FHRS Brian Solomon Gaston A. Cudemus, MD Ricardo Martinez-Ruiz David R. Axline, MD, FACC Gorav Ailawadi

Braunwald reverses 35 year old stance in asymptomatic severe aortic stenosis &AVR bit.ly/3EBr0Tt Don’t wait for symptoms to develop in severe AS! No more “watchful waiting” #justdoit Act & send patient for TAVR or SAVR JAMA Cardiology


BKING NEWS! announcing the arrival of Thomas G. Caranasos MD as the new J. Yeh Endowed Chair of CardioThor Surg & VP of Rooney Heart Institute, bringing vast experience to SWFL in complex valve ds, aortopathies & advanced HF Thomas Caranasos AATS The Society of Thoracic Surgeons NCH Rooney Heart Institute


#SGLT2 inhibitors may slow the progression of nonsevere aortic stenosis, according to a study published in #JACCINT. Learn more: bit.ly/4hOrOmA #vhdAS #cvVHD JACC Journals


Long-term treatment with finerenone is estimated to extend event-free survival by up to 3 years among people with HF with mildly reduced or preserved ejection fraction. ja.ma/4i9tO8Q Muthu Vaduganathan


According to an updated meta-analysis including 6 RCTs and 5,341 low-risk patients, #TAVR was associated with a reduced hazard of death and death or disabling stroke compared with #SAVR, while rates of stroke were equivalent jacc.org/doi/10.1016/j.… JACC Journals





World Premiere: first commercially approved transseptal mitral valve at Universitätsmedizin Mainz - the SAPIEN M3 TMVR - many more patients in the future. 🚀#PCR Mitral Focus Group Univ.-Prof. Dr. Ralph Stephan von Bardeleben AGIK Deutsche Gesellschaft für Kardiologie Edoardo Zancanaro MD Erik Rafflenbeul European Society of Cardiology Journals Holger Thiele


TAVR for patients with Aortic Regurgitation (AR). Now available. Actively enrolling in the JOURNEY clinical trial NCH Rooney Heart Institute NCH Healthcare System For more information please call 239-624-8387


Today, we broke ground on the RM Schulze Family Heart & Stroke Critical Care Center — future home of the NCH Rooney Heart Institute & NCH Wingard Stroke Institute. This innovative center will bring together world-class cardiac, vascular, and stroke care under one roof, right here in SWFL.

